Ultra Sounded Guided Posterior Transverse Abdominis Plane & Lateral FEMORAL Cutaneous Nerve Blocks Analgesia Post Hip Hemiarthroplasty

COMBINED ULTRASOUND GUIDED POSTERIOR TRANS VERSUS ABDOMINAL PLANE & LATERAL FEMORAL CUTANEOUS NERVE BLOCKS FOR POSTOPERATIVE ANALGESIA AFTER HIP HEMIARTHROPLASTIC SURGERY

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dubai Health Authority

Dubai, United Arab Emirates

About this study

TO EVALUATE THE EFFECTIVENESS OF POSTOPERATIVE ANALGESIA FOR HIP HEMIARTHROPLASTIC SURGERIES BY USING ULTRASOUND GUIDED POSTERIOR TRANS VERSUS ABDOMINAL PLANE & LATERAL FEMORAL CUTANEOUS NERVE BLOCKS

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hemiarthroplaty surgery
ASA 1 - ASA 4

Exclusion criteria

ALLERGIC TO LOCAL ANESTHETICS
PATIENT REFUSAL

Treatment and study plan

Primary outcomes

PAIN MANAGEMENT

Time frame: 2 DAYS

POSTOPERATIVE ANALGESIA

Sponsors and collaborators

Lead sponsor

Dubai Health Authority

Other Gov

Registry information

Official study title

Effectiveness Of Ultra Sounded Guided Posterior Transverses Abdominis Plane & Lateral Femoral Cutaneous Nerve Blocks For Analgesia After Hip Hemiarthroplasty

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Jul 17, 2020
Registry last updated: Aug 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed